The Shelleys discuss unique cases such as a dramatic example of swimmer's itch, Bell's palsy, trichoepitheliomas, scalp psoriasis, and others. They also provide an interesting commentary on the US Food and Drug Administration's policy, new in 1991, for restricting drug companies from making claims for new but unapproved uses of their approved products.
More News